ReviewCell communication and signaling : CCS2026
Phase separation and the tumor microenvironment.
Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Liquid-Liquid Phase Separation (LLPS) is a physicochemical process which involves biomolecules spontaneously assembling into membrane-less biomolecular condensates through multivalent weak interactions. It emerges as a key factor regulating cellular homeostasis, and is widely involved in the spatiotemporal regulation of core cellular activities including gene expression and signal transduction. Notably, the dynamic process of LLPS is highly sensitive to extracellular microenvironmental cues, especially in the context of cancer. The Tumor Microenvironment (TME) is a dynamically heterogeneous environment characterized by metabolic dysregulation such as lactate accumulation and acidosis, hypoxia, nutrient deprivation, cytokine imbalance, and abnormal physicochemical signals. Accumulating evidence indicates that this specialized microenvironment exerts a profound regulatory effect on LLPS dynamics. This review systematically analyzes the bidirectional interaction between LLPS and TME, as well as the emerging opportunities to understand and influence tumor progression and emergence of therapeutic resistance by focusing on TME-LLPS crosstalk. We also highlight core challenges in this field, including the heterogeneity of LLPS and the associated dynamic processes, and the lack of tools for accurately monitoring condensate behavior in vivo. These opportunities and challenges motivate future research directions, focusing on the development of high-resolution LLPS imaging technologies, single-cell LLPS omics technologies, and therapeutic approaches targeting vulnerable sites of TME-LLPS such as YAP-TEAD condensate disruptors and pH-responsive modulators. Deciphering the LLPS-TME regulatory network is expected to provide support for redefining tumor heterogeneity and promoting the development of precision oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.